JP2024519993A5 - - Google Patents
Info
- Publication number
- JP2024519993A5 JP2024519993A5 JP2023572661A JP2023572661A JP2024519993A5 JP 2024519993 A5 JP2024519993 A5 JP 2024519993A5 JP 2023572661 A JP2023572661 A JP 2023572661A JP 2023572661 A JP2023572661 A JP 2023572661A JP 2024519993 A5 JP2024519993 A5 JP 2024519993A5
- Authority
- JP
- Japan
- Prior art keywords
- groups
- group
- homologous
- heterocyclyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110606803 | 2021-05-27 | ||
| CN202110606803.1 | 2021-05-27 | ||
| CN202110976020 | 2021-08-24 | ||
| CN202110976020.2 | 2021-08-24 | ||
| PCT/CN2022/095441 WO2022247920A1 (zh) | 2021-05-27 | 2022-05-27 | 喹啉胺类化合物、其制备方法及其在医药上的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519993A JP2024519993A (ja) | 2024-05-21 |
| JP2024519993A5 true JP2024519993A5 (https=) | 2025-05-16 |
Family
ID=84228425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572661A Pending JP2024519993A (ja) | 2021-05-27 | 2022-05-27 | キノリンアミン系化合物、その調製方法及びその医薬的応用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240327388A1 (https=) |
| EP (1) | EP4349831A4 (https=) |
| JP (1) | JP2024519993A (https=) |
| KR (1) | KR20240014059A (https=) |
| CN (1) | CN117222639A (https=) |
| AU (1) | AU2022283404A1 (https=) |
| BR (1) | BR112023024741A2 (https=) |
| CA (1) | CA3219657A1 (https=) |
| MX (1) | MX2023013972A (https=) |
| TW (1) | TW202313592A (https=) |
| WO (1) | WO2022247920A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120152971A (zh) * | 2022-11-25 | 2025-06-13 | 江苏恒瑞医药股份有限公司 | 一种喹啉胺类化合物晶型及其制备方法 |
| WO2024109937A1 (zh) * | 2022-11-25 | 2024-05-30 | 江苏恒瑞医药股份有限公司 | 一种喹啉胺类化合物的可药用盐、晶型及其制备方法 |
| CN116854634B (zh) * | 2023-06-27 | 2025-12-09 | 广东药科大学 | 一种选择性ces2抑制剂、其制备方法及其作为药物的用途 |
| CN121532389A (zh) * | 2023-08-30 | 2026-02-13 | 江苏正大丰海制药有限公司 | 用于调节微小rna-124活性的化合物 |
| WO2025201294A1 (zh) * | 2024-03-26 | 2025-10-02 | 深圳信立泰药业股份有限公司 | 一种吲哚类化合物及其制备方法与miR上调应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5648599A (en) * | 1998-09-11 | 2000-04-03 | Kyorin Pharmaceutical Co. Ltd. | Phosphonic ester derivatives and process for producing the same |
| SI2440547T1 (sl) | 2009-06-12 | 2023-05-31 | Abivax | Nove kemične molekule, ki zavirajo mehanizem spajanja za zdravljenje bolezni, ki so posledica napak pri spajanju |
| JP2011026251A (ja) * | 2009-07-27 | 2011-02-10 | Kowa Co | ２−アリールアミノキノリン化合物及びこれを有効成分として含有するエリスロポエチン産生促進剤 |
| WO2012037351A1 (en) | 2010-09-17 | 2012-03-22 | Glaxosmithkline Llc | Compounds |
| CN104109165A (zh) | 2013-04-19 | 2014-10-22 | 四川海思科制药有限公司 | 4,5-二氢-吡唑并[3,4-c]吡啶-2-酮衍生物、其制备方法以及应用 |
| CN105530938B (zh) | 2013-07-05 | 2019-10-22 | Abivax公司 | 用于治疗由逆转录病毒引起的疾病的化合物 |
| EP2974729A1 (en) * | 2014-07-17 | 2016-01-20 | Abivax | Quinoline derivatives for use in the treatment of inflammatory diseases |
| EP3059236A1 (en) * | 2015-02-23 | 2016-08-24 | Abivax | A new quinoline derivative for use in the treatment and prevention of viral infections |
| PT3429998T (pt) | 2016-03-18 | 2021-11-04 | Prosynergia S A R L | Processo para preparação de derivados de quinolin-2-il-fenilamina e seus sais |
| EP3669873A1 (en) * | 2018-12-20 | 2020-06-24 | Abivax | Quinoline derivatives for use ine the traeatment of inflammation diseases |
| WO2021151062A1 (en) * | 2020-01-24 | 2021-07-29 | The Trustees Of Princeton Univeristy | Heterocyclic compounds and uses thereof |
-
2022
- 2022-05-27 TW TW111119883A patent/TW202313592A/zh unknown
- 2022-05-27 WO PCT/CN2022/095441 patent/WO2022247920A1/zh not_active Ceased
- 2022-05-27 BR BR112023024741A patent/BR112023024741A2/pt unknown
- 2022-05-27 MX MX2023013972A patent/MX2023013972A/es unknown
- 2022-05-27 KR KR1020237043944A patent/KR20240014059A/ko active Pending
- 2022-05-27 AU AU2022283404A patent/AU2022283404A1/en active Pending
- 2022-05-27 US US18/564,512 patent/US20240327388A1/en active Pending
- 2022-05-27 CN CN202280030768.6A patent/CN117222639A/zh active Pending
- 2022-05-27 JP JP2023572661A patent/JP2024519993A/ja active Pending
- 2022-05-27 CA CA3219657A patent/CA3219657A1/en active Pending
- 2022-05-27 EP EP22810644.9A patent/EP4349831A4/en active Pending